Total T-Helper-1 Cell
Whole Blood

The Total T-Helper-1 Cell marker serves as a critical component in the evaluation of immune system functionality, particularly in the adaptive immune response. T-Helper-1 (Th1) cells are a subset of CD4+ T cells, which are pivotal in orchestrating the body's defense against intracellular pathogens, such as viruses and certain bacteria, by producing a specific profile of cytokines, including interferon-gamma (IFN-γ), tumor necrosis factor-alpha (TNF-α), and interleukin-2 (IL-2). These cytokines not only help in the activation of macrophages and the enhancement of their phagocytic activity but also play a crucial role in promoting the differentiation of CD8+ T cells into cytotoxic T lymphocytes, thereby aiding in the clearance of infected cells. The Lymphocyte MAP panel, through quantification and analysis of the Total T-Helper-1 Cell marker, provides invaluable insights into the Th1-mediated immune response, facilitating the diagnosis and management of conditions associated with immune dysregulation. By monitoring changes in Th1 cell populations, healthcare providers can assess the shift in immune response towards a Th1 or Th2 dominance, which is fundamental in understanding the pathophysiology of various autoimmune diseases, allergic conditions, and in crafting personalized immunomodulatory strategies.

The Total T-Helper-17 (Th17) marker is a critical component in evaluating immune system functionality, particularly in the context of immune response regulation. T-Helper 17 (Th17) cells, a subset of pro-inflammatory T-helper cells, play a pivotal role in the immune system, primarily involved in the defense against pathogens and in the pathogenesis of various autoimmune and inflammatory diseases. The Th17 marker is crucial for understanding the dynamics of immune responses, especially in conditions where the immune system may be overactive or imbalanced. Th17 cells produce interleukin-17 (IL-17), a cytokine that triggers inflammation and has been linked to the pathogenesis of several autoimmune and inflammatory conditions, including psoriasis, rheumatoid arthritis, and inflammatory bowel disease. Elevated levels of Th17 cells can signify a heightened inflammatory state, suggesting a predisposition or existing condition of autoimmunity or chronic inflammation.

Total T-Helper-2 Cell
Whole Blood

Total T-Helper-2 (Th2) cells are a subset of the CD4+ T cells, playing a pivotal role in the adaptive immune response. They are characterized by their function in helping B cells to produce antibodies and are crucial in the defense against extracellular pathogens, such as bacteria and parasites. This evaluation is particularly relevant in the context of allergic responses, autoimmune disorders, and chronic inflammatory conditions, where a shift towards a Th2-dominant response can indicate an imbalance in immune regulation. The measurement of Th2 cells within this panel provides insights into the Th1/Th2 balance, an essential aspect for understanding various pathological conditions and guiding therapeutic strategies. By monitoring Th2 levels, healthcare providers can gain valuable information about an individual's immune status, facilitating personalized medical interventions aimed at restoring immune equilibrium and mitigating disease progression.

Total Tau
Cerebrospinal fluid (CSF)

Total Tau in CSF is a biomarker used to assess neuronal damage and degeneration, particularly in the context of neurodegenerative diseases. Tau is a protein primarily found in neurons, where it stabilizes microtubules essential for cellular transport. Elevated levels of total tau in cerebrospinal fluid (CSF) are often associated with conditions such as Alzheimer’s disease, where neuronal damage leads to the release of tau into the CSF. Increased tau can also indicate acute brain injuries, such as stroke, traumatic brain injury, or other neurodegenerative disorders. In Alzheimer’s disease, total tau is typically elevated alongside phosphorylated tau (pTau), which reflects pathological tau phosphorylation processes, distinguishing it from other neurodegenerative diseases. The measurement of total tau in CSF, combined with other markers like amyloid-beta (Aβ) peptides and pTau, provides valuable insights into the underlying pathology, aiding in early diagnosis, prognosis, and differentiation of dementia-related conditions.

Total Testosterone in the context of a female hormone panel refers to the total amount of testosterone present in a woman's blood, measured in nanograms per milliliter (ng/mL). Testosterone, commonly associated with male health, is actually an important hormone in females as well, albeit in lower concentrations. It plays a critical role in muscle strength, bone density, and the functioning of the reproductive organs. Additionally, it influences libido, mood, and overall energy levels. The normal range of total testosterone in women varies depending on factors such as age and health conditions, but it generally falls between 15 to 70 ng/mL. Levels outside this range can indicate various health issues. For example, higher levels might suggest conditions like polycystic ovary syndrome (PCOS), which can lead to symptoms like irregular menstrual cycles, acne, and excessive hair growth. On the other hand, lower levels might be a sign of adrenal insufficiency or the menopausal transition, potentially contributing to decreased muscle mass, fatigue, and a diminished sex drive. Understanding the level of total testosterone is essential for diagnosing and managing potential health concerns in females, highlighting the importance of including this marker in hormone panels.

Omega-3 polyunsaturated fatty acids (n-3 PUFAs) have been linked to healthy aging throughout our lifespan - from fetal development to prevention of Alzheimer’s disease. Omega-3 fatty acids are anti-inflammatory and used in cell membrane production, function, and overall gene expression. Most standard American diets are deficient in common n-3 food sources such as flax, oily fish, nuts, and green leafy vegetables. Deficiencies in n-3 have been correlated with many clinical conditions such as neurodevelopmental and behavioral disorders, cardiovascular disease, cognitive decline, mood disorders, skin abnormalities, visual changes, and cancer. References: - Lee JM, Lee H, Kang S, Park WJ. Fatty Acid Desaturases, Polyunsaturated Fatty Acid Regulation, and Biotechnological Advances. Nutrients. 2016;8(1). - Swanson D, Block R, Mousa SA. Omega-3 Fatty Acids EPA and DHA: Health Benefits Throughout Life. Advances in Nutrition. 2012;3(1):1-7. - Richardson AJ. Omega-3 fatty acids in ADHD and related neurodevelopmental disorders. International review of psychiatry. 2006;18(2):155-172. - Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. circulation. 2002;106(21):2747-2757. - SanGiovanni JP, Chew EY. The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Progress in retinal and eye research. 2005;24(1):87- 138. - McCusker MM, Grant-Kels JM. Healing fats of the skin: the structural and immunologic roles of the ω-6 and ω-3 fatty acids. Clinics in dermatology. 2010;28(4):440-451. - Riediger ND, Othman RA, Suh M, Moghadasian MH. A systemic review of the roles of n-3 fatty acids in health and disease. J Am Diet Assoc. 2009;109(4):668-679. - Borow KM, Nelson JR, Mason RP. Biologic plausibility, cellular effects, and molecular mechanisms of eicosapentaenoic acid (EPA) in atherosclerosis. Atherosclerosis. 2015;242(1):357-366. - Chang JP, Su KP, Mondelli V, Pariante CM. Omega-3 Polyunsaturated Fatty Acids in Youths with Attention Deficit Hyperactivity Disorder: a Systematic Review and Meta-Analysis of Clinical Trials and Biological Studies. Neuropsychopharmacology. 2018;43(3):534-545. - Cormier H, Rudkowska I, Lemieux S, Couture P, Julien P, Vohl M-C. Effects of FADS and ELOVL polymorphisms on indexes of desaturase and elongase activities: results from a pre-post fish oil supplementation. Genes & nutrition. 2014;9(6):437. - Das UN. Arachidonic acid in health and disease with focus on hypertension and diabetes mellitus: A review. Journal of advanced research. 2018;11:43-55.

Total WBC
Whole Blood

The Total WBC (White Blood Cell) count measures the total number of white blood cells present in the blood, which are essential components of the immune system. White blood cells are responsible for defending the body against both infectious disease and foreign materials. In the context of the Lymphocyte MAP panel, the Total WBC count serves as a foundational assessment of the immune system's overall state. A normal range of WBC indicates a balanced immune response, whereas deviations from this range can signal various health conditions. For instance, a higher than normal WBC count (leukocytosis) can indicate an inflammatory response, infection, stress, or more serious conditions like leukemia. Conversely, a lower than normal count (leukopenia) can suggest a compromised immune system, potentially due to bone marrow deficiencies, autoimmune disorders, or the effects of certain medications. Given the complex nature of immune responses, the Total WBC count in the Lymphocyte MAP panel is not evaluated in isolation. Instead, it is considered in conjunction with other markers and immunotypes. This comprehensive approach allows for a more accurate and nuanced understanding of a person's immune health. Analyzing the Total WBC in context helps to distinguish between various immune system states, such as immune balance, dominance of specific cell types (like T or B cells), immune hyperactivity, deficiency, and regulatory cell imbalances. Each of these states can have significant implications for diagnosing and treating a range of conditions, from infections and allergies to autoimmune diseases and cancer. The Total WBC count is, therefore, a vital parameter within the Lymphocyte MAP panel, offering essential insights into the functioning and balance of the immune system. Its interpretation, especially within the framework of this comprehensive panel, provides valuable information for personalized medical approaches and the management of various health conditions.

Toxoplasma gondii is a protozoan parasite that infects most species of warm-blooded animals, including humans, and causes the disease toxoplasmosis. Tick based transmission has been increasingly considered and evidence indicates that T. gondii could be a potentially unrecognized tick-borne pathogen spreading toxoplasmosis . The parasite forms cysts that can affect almost any part of the body often your brain and muscle tissue of different organs, including the heart. The immune system keeps the parasites in check in an inactive state however, if it is weakened by disease or certain medications, the infection can be reactivated, leading to serious complications.

What is Toxoplasma gondii MIC3 – IgM? Toxoplasma gondii is a microscopic parasite that causes toxoplasmosis, a common infection that often goes unnoticed in healthy individuals but can pose serious risks during pregnancy or in people with weakened immune systems. It is typically transmitted through undercooked meat, contaminated water or soil, or contact with cat feces. The MIC3 – IgM test detects IgM antibodies against the MIC3 protein, which is one of the parasite’s microneme proteins involved in host cell invasion. IgM antibodies are the first antibodies produced by your immune system in response to infection and generally appear within 1–2 weeks after initial exposure. Therefore, this test helps identify a recent or current infection with Toxoplasma gondii.

What is Toxoplasma gondii p29 – IgM? Toxoplasma gondii is a microscopic parasite that causes toxoplasmosis, a common infection that is often mild or asymptomatic in healthy people but can be serious in pregnant individuals, newborns, or people with weakened immune systems. The parasite is usually transmitted through undercooked meat, contaminated food or water, or exposure to infected cat feces. The p29 – IgM test detects IgM antibodies targeting the p29 protein, a specific surface antigen expressed by Toxoplasma gondii. IgM antibodies are the first antibodies produced by the immune system in response to infection, typically appearing within 1 to 2 weeks of exposure. This test helps identify recent or active infection.

What is Toxoplasma gondii p30 – IgG? Toxoplasma gondii is a microscopic parasite that causes toxoplasmosis, a common infection that is often mild in healthy individuals but can cause serious complications in pregnant women, newborns, and immunocompromised individuals. People typically become infected by eating undercooked meat, drinking contaminated water, or coming into contact with cat feces that contain the parasite. The p30 – IgG test detects IgG antibodies against the p30 protein, also known as SAG1 (surface antigen 1), which is one of the most abundant and immunologically important proteins on the surface of T. gondii. IgG antibodies usually appear 1 to 2 weeks after infection and can remain in the body for years or even a lifetime, indicating past exposure and likely immunity.

What is Toxoplasma gondii p30 – IgM? Toxoplasma gondii is a common parasite that causes toxoplasmosis, an infection often mild or unnoticed in healthy individuals but potentially serious in pregnant women, newborns, or people with weakened immune systems. It is usually spread through undercooked meat, contaminated food or water, or contact with infected cat feces. The p30 – IgM test measures IgM antibodies directed against the p30 protein (also known as SAG1, a major surface antigen) of Toxoplasma gondii. IgM antibodies are produced early in an infection—typically within 1 to 2 weeks of exposure—and serve as a marker for recent or active infection.

Part of Other

can show whether you had previous exposure to or recent infection with Toxoplasma gondii